TY - JOUR
T1 - Reduced folate carrier polymorphisms and neural tube defect risk
AU - O'Leary, Valerie B.
AU - Pangilinan, Faith
AU - Cox, Christopher
AU - Parle-McDermott, Anne
AU - Conley, Mary
AU - Molloy, Anne M.
AU - Kirke, Peadar N.
AU - Mills, James L.
AU - Brody, Lawrence C.
AU - Scott, John M.
N1 - Funding Information:
This research was supported in part by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH, and DHHS, and also supported by the Health Research Board of Ireland who provided the funding for the ABI Prism 377 automated DNA sequencer. Faith Pangilinan is supported by a Pharmacology Research Associate Fellowship from the National Institute of General Medical Sciences, National Institutes of Health. We thank Marie Sutton, Maeve Royston, Helen Burke, Mary-Patricia Mc Keever, and Sharon Murray for subject recruitment and data collection. We thank the IASBAH, the Public Health Nurses and the three Dublin Maternity Hospitals (National Maternity Hospital Holles Street, The Coombe Women’s Hospital, and The Rotunda Hospital) for their assistance with subject and control recruitment. We thank Regina Dempsey, Tracey Claxton, and Sinead Cocchiglia for their technical assistance.
PY - 2006/4
Y1 - 2006/4
N2 - The reduced folate carrier (RFCI) is essential for folate transport into cells. Low folate is an important cause of neural tube defects (NTDs), and a single-nucleotide polymorphism (H27R) (80G→A) in the RFCI gene has been reported to be a NTD risk factor. We investigated H27R and a 61bp tandem repeat polymorphism as potential risk factors for NTDs, using a large homogeneous Irish population by case/control comparison, log-linear analysis, and transmission disequilibrium testing. No association was found between NTDs and H27R in mothers [p = 0.23, odds ratio (OR) 0.87, 95% confidence interval (CI) 0.69-1.09], fathers (p = 0.11, OR 0.83, 95% CI 0.66-1.04), or cases (p = 0.36, OR 0.9, 95% CI 0.72-1.12) when compared to controls or through log-linear modeling for dominant or recessive effects or with the transmission disequilibrium test for preferential allele transmission. Using log-linear models, a significant protective case effect was seen for the 61 bp polymorphism (p = 0.0039, OR 0.21, 95% CI 0.05-0.85). When analyzed by genotype, individuals homozygous for a single copy of the 61 bp sequence were underrepresented in cases as compared to controls, although these results did not reach statistical significance (p = 0.081, OR 0.5, 95% CI 0.23-1.09, goodness of fit p = 0.42). We compared the frequencies of H27R and the 61 bp polymorphism in African-Americans and American-Caucasians. The frequencies of H27R polymorphism differed significantly between the two populations (p = 0.0001). This large study does not confirm previous reports that H27R is a risk factor for NTDs. The previously unstudied 61 bp tandem repeat, however, has a possible protective NTD effect in our Irish population. This requires confirmation in other studies.
AB - The reduced folate carrier (RFCI) is essential for folate transport into cells. Low folate is an important cause of neural tube defects (NTDs), and a single-nucleotide polymorphism (H27R) (80G→A) in the RFCI gene has been reported to be a NTD risk factor. We investigated H27R and a 61bp tandem repeat polymorphism as potential risk factors for NTDs, using a large homogeneous Irish population by case/control comparison, log-linear analysis, and transmission disequilibrium testing. No association was found between NTDs and H27R in mothers [p = 0.23, odds ratio (OR) 0.87, 95% confidence interval (CI) 0.69-1.09], fathers (p = 0.11, OR 0.83, 95% CI 0.66-1.04), or cases (p = 0.36, OR 0.9, 95% CI 0.72-1.12) when compared to controls or through log-linear modeling for dominant or recessive effects or with the transmission disequilibrium test for preferential allele transmission. Using log-linear models, a significant protective case effect was seen for the 61 bp polymorphism (p = 0.0039, OR 0.21, 95% CI 0.05-0.85). When analyzed by genotype, individuals homozygous for a single copy of the 61 bp sequence were underrepresented in cases as compared to controls, although these results did not reach statistical significance (p = 0.081, OR 0.5, 95% CI 0.23-1.09, goodness of fit p = 0.42). We compared the frequencies of H27R and the 61 bp polymorphism in African-Americans and American-Caucasians. The frequencies of H27R polymorphism differed significantly between the two populations (p = 0.0001). This large study does not confirm previous reports that H27R is a risk factor for NTDs. The previously unstudied 61 bp tandem repeat, however, has a possible protective NTD effect in our Irish population. This requires confirmation in other studies.
KW - 61 bp tandem repeat
KW - Folate
KW - H27R
KW - Neural tube defect
KW - Reduced folate carrier
UR - http://www.scopus.com/inward/record.url?scp=33645118135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645118135&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2005.09.024
DO - 10.1016/j.ymgme.2005.09.024
M3 - Article
C2 - 16343969
AN - SCOPUS:33645118135
SN - 1096-7192
VL - 87
SP - 364
EP - 369
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
IS - 4
ER -